Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1979 1
1983 1
1984 1
1985 1
1988 2
1989 1
1990 3
1991 2
1992 11
1993 8
1994 2
1995 5
1996 2
1997 4
1998 7
1999 5
2000 7
2001 10
2002 7
2003 13
2004 22
2005 15
2006 5
2007 19
2008 18
2009 12
2010 14
2011 15
2012 12
2013 9
2014 15
2015 13
2016 5
2017 9
2018 9
2019 9
2020 7
2021 4
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 17015905

280 results
Results by year
Filters applied: . Clear all
Page 1
Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial.
Bodet-Milin C, Faivre-Chauvet A, Carlier T, Rauscher A, Bourgeois M, Cerato E, Rohmer V, Couturier O, Drui D, Goldenberg DM, Sharkey RM, Barbet J, Kraeber-Bodere F. Bodet-Milin C, et al. J Nucl Med. 2016 Oct;57(10):1505-1511. doi: 10.2967/jnumed.116.172221. Epub 2016 May 26. J Nucl Med. 2016. PMID: 27230928 Free article. Clinical Trial.
Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts.
Schoffelen R, Sharkey RM, Goldenberg DM, Franssen G, McBride WJ, Rossi EA, Chang CH, Laverman P, Disselhorst JA, Eek A, van der Graaf WT, Oyen WJ, Boerman OC. Schoffelen R, et al. Mol Cancer Ther. 2010 Apr;9(4):1019-27. doi: 10.1158/1535-7163.MCT-09-0862. Epub 2010 Mar 30. Mol Cancer Ther. 2010. PMID: 20354120 Free PMC article.
280 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page